Oral JAK inhibitor LEQSELVI (deuruxolitinib) approved by US FDA for severe alopecia areata treatment Read more
Pfizer’s gene therapy for Haemophilia A receives positive topline results from Phase 3 Study Read more
Alembic gains USFDA final approval for Fluphenazine Hydrochloride Tablets USP, 1 mg, 2.5 mg, 5 mg, and 10 mg Read more
Gland Pharma receives tentative USFDA approval for Latanoprostene Bunod Ophthalmic Solution Read more
ZIM Laboratories gains approval to market Azithromycin for Oral Suspension 200 mg/5ml (40 mg/ml) in Portugal Read more
Glenmark Pharmaceuticals receives ANDA approval for Topiramate Capsules USP, 15 mg and 25 mg Read more